I-MAB SPONS.ADS/1 -0001 (0VY) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.063x

Based on the latest financial reports, I-MAB SPONS.ADS/1 -0001 (0VY) has a cash flow conversion efficiency ratio of -0.063x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-14.60 Million ≈ $-17.06 Million USD) by net assets (€230.94 Million ≈ $269.99 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See I-MAB SPONS.ADS/1 -0001 balance sheet quality to measure how much of total assets are equity-financed.

I-MAB SPONS.ADS/1 -0001 - Cash Flow Conversion Efficiency Trend (2021–2025)

This chart illustrates how I-MAB SPONS.ADS/1 -0001's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check I-MAB SPONS.ADS/1 -0001 (0VY) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

I-MAB SPONS.ADS/1 -0001 Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of I-MAB SPONS.ADS/1 -0001 ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Chicago Atlantic BDC, Inc. NASDAQ:LIEN	0.000x
Kisco Holdings KO:001940	-0.018x
BVZ Holding AG SW:BVZN	0.079x
HMS Bergbau AG XETRA:HMU	-0.399x
Bastas Baskent Cimento Sanayi ve Ticaret AS IS:BASCM	0.160x
TERACT EO 1 F:6O8	N/A
Stellus Capital Investment NYSE:SCM	0.063x
Yongyue Science & Tech Co Ltd SHG:603879	-0.044x

Annual Cash Flow Conversion Efficiency for I-MAB SPONS.ADS/1 -0001 (2021–2025)

The table below shows the annual cash flow conversion efficiency of I-MAB SPONS.ADS/1 -0001 from 2021 to 2025. For the full company profile with market capitalisation and key ratios, see I-MAB SPONS.ADS/1 -0001 (0VY) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€230.94 Million ≈ $269.99 Million	€-20.60 Million ≈ $-24.08 Million	-0.089x	+65.94%
2024-12-31	€201.16 Million ≈ $235.18 Million	€-52.67 Million ≈ $-61.58 Million	-0.262x	+12.63%
2023-12-31	€242.58 Million ≈ $283.61 Million	€-72.70 Million ≈ $-84.99 Million	-0.300x	-154.92%
2022-12-31	€421.77 Million ≈ $493.09 Million	€-49.58 Million ≈ $-57.97 Million	-0.118x	+44.92%
2021-12-31	€715.33 Million ≈ $836.29 Million	€-152.66 Million ≈ $-178.48 Million	-0.213x	--

About I-MAB SPONS.ADS/1 -0001

F:0VY Germany Biotechnology

Market Cap

$206.86 Million

€176.94 Million EUR

Market Cap Rank

#16375 Global

#1563 in Germany

Share Price

€1.53

Change (1 day)

+0.00%

52-Week Range

€1.25 - €5.60

All Time High

€70.00